Risk of postacute sequelae of COVID-19 and oral antivirals in adults aged over 60 years: A nationwide retrospective cohort study
Nirmatrelvir/ritonavir and molnupiravir administration in ambulatory patients were associated with decreased PASC risk; thus, oral antivirals may mitigate the indirect Severe acute respiratory syndrome coronavirus 2 infection effects.
Authors
- Poong Hoon Lee (ORCID: https://orcid.org/0000-0001-8258-2152)
- Kyungmin Huh (ORCID: https://orcid.org/0000-0002-5140-3964)
- Gi Hwan Bae
- Jaehun Jung (ORCID: https://orcid.org/0000-0002-4856-3668)
- Dong-Hwi Kim (ORCID: https://orcid.org/0000-0002-3181-0917)
- Min‐Gyu Yoo (ORCID: https://orcid.org/0000-0002-8153-6813)
- Hye Jin Joo (ORCID: https://orcid.org/0000-0003-1683-1143)
- Eunji Kim (ORCID: https://orcid.org/0000-0002-1306-4105)
- Geun Woo Lee (ORCID: https://orcid.org/0000-0002-1459-1652)
- Jungyeon Kim (ORCID: https://orcid.org/0000-0003-2732-1544)
- Hyungmin Lee (ORCID: https://orcid.org/0000-0003-3478-3704)
- Hee Sun Jung
- Il Uk Jo
Institutions
- Gachon University (KR)
- Korea University (KR)
- Samsung Medical Center (KR)
- Health Insurance Review and Assessment Service (KR)
- Korea Disease Control and Prevention Agency (KR)
- Korea University (JP)
Publication Details
- Journal
- International Journal of Infectious Diseases
- Published
- 2025-02-24
- DOI
- https://doi.org/10.1016/j.ijid.2025.107850
- Citations
- 3
- Primary Topic
- Long-Term Effects of COVID-19
- Type
- article
- Field-Weighted Citation Impact
- 4.17
Funders
- Korea Health Industry Development Institute
- National Research Foundation of Korea